Pathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216.

dc.contributor.authorGopcevic, Kristina R
dc.contributor.authorGkaliagkousi, Eugenia
dc.contributor.authorNemcsik, János
dc.contributor.authorAcet, Ömür
dc.contributor.authorBernal-Lopez, M Rosa
dc.contributor.authorBruno, Rosa M
dc.contributor.authorClimie, Rachel E
dc.contributor.authorFountoulakis, Nikolaos
dc.contributor.authorFraenkel, Emil
dc.contributor.authorLazaridis, Antonios
dc.contributor.authorNavickas, Petras
dc.contributor.authorRochfort, Keith D
dc.contributor.authorŠatrauskienė, Agnė
dc.contributor.authorZupkauskienė, Jūratė
dc.contributor.authorTerentes-Printzios, Dimitrios
dc.date.accessioned2025-01-07T12:20:38Z
dc.date.available2025-01-07T12:20:38Z
dc.date.issued2021-12-14
dc.description.abstractImpairment of the arteries is a product of sustained exposure to various deleterious factors and progresses with time; a phenomenon inherent to vascular aging. Oxidative stress, inflammation, the accumulation of harmful agents in high cardiovascular risk conditions, changes to the extracellular matrix, and/or alterations of the epigenetic modification of molecules, are all vital pathophysiological processes proven to contribute to vascular aging, and also lead to changes in levels of associated circulating molecules. Many of these molecules are consequently recognized as markers of vascular impairment and accelerated vascular aging in clinical and research settings, however, for these molecules to be classified as biomarkers of vascular aging, further criteria must be met. In this paper, we conducted a scoping literature review identifying thirty of the most important, and eight less important, biomarkers of vascular aging. Herein, we overview a selection of the most important molecules connected with the above-mentioned pathological conditions and study their usefulness as circulating biomarkers of vascular aging.
dc.identifier.doi10.3389/fphys.2021.789690
dc.identifier.issn1664-042X
dc.identifier.pmcPMC8712891
dc.identifier.pmid34970157
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8712891/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphys.2021.789690/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24489
dc.journal.titleFrontiers in physiology
dc.journal.titleabbreviationFront Physiol
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.number789690
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcellular matrix
dc.subjectcirculating biomarkers
dc.subjectepigenetics
dc.subjectinflammation
dc.subjectoxidative stress
dc.subjectvascular aging
dc.titlePathophysiology of Circulating Biomarkers and Relationship With Vascular Aging: A Review of the Literature From VascAgeNet Group on Circulating Biomarkers, European Cooperation in Science and Technology Action 18216.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8712891.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format